A protein that can lower high cholesterol could slow the progression of age-related macular degeneration (AMD), according to a study in mice and human tissue by researchers at the Washington University School of Medicine in St. Louis.

“Our study points to a possible way to address a major unmet clinical need,” senior author Rajendra S. Apte, M.D., Ph.D., the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences at WashU Medicine, said in a news release . “Current therapies that reduce the chance of further vision loss are limited to only the most advanced stages of macular degeneration and do not reverse the disease.”

Age-related macular degeneration (AMD) is a leading cause of blindness in people over the age of 50. It's an eye disease that causes damage to the ma

See Full Page